KPS to sell DexKo to Brookfield’s PE group in $3.4bn deal

DexKo, valued at $3.4 billion in the deal, was acquired by KPS in 2017 from The Sterling Group, who retained a minority ownership stake.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this